Pfizer narrows its focus and profit soars in 3Q

This post was originally published on this site

Pfizer’s third-quarter profit nearly doubled after it booked an $8.1 billion gain on paper by creating a consumer health products joint venture, a key part of the drugmaker’s plan to slim down and focus on innovative medicines. Those include blockbusters like …

Click here to read full article